Campbell & Co Investment Adviser’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Buy
+21,021
New +$667K 0.03% 712
2025
Q3
– Sell
-33,495
Closed -$804K – 1351
2025
Q2
$804K Buy
+33,495
New +$777K 0.05% 598
2024
Q2
– Sell
-8,964
Closed -$270K – 1306
2024
Q1
$270K Sell
8,964
-4,662
-34% -$129K 0.02% 944
2023
Q4
$390K Sell
13,626
-39,115
-74% -$1.15M 0.04% 821
2023
Q3
$1.95M Buy
52,741
+5,163
+11% +$197K 0.23% 94
2023
Q2
$1.86M Buy
+47,578
New +$1.86M 0.33% 33

Other funds holding RTO

Campbell & Co Investment Adviser's RTO Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Rentokil (RTO) in Q2 2026: 21,021 shares worth $601K. The stake represents 0.03% of the portfolio and ranks #712 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in RTO as recently as Q2 2025.

Campbell & Co Investment Adviser first reported a position in RTO in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.95M in Q3 2023. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Campbell & Co Investment Adviser held 21,021 shares of Rentokil worth $601K as of Q2 2026.
  • Rentokil was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Rentokil made up 0.03% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #712 holding.
  • Campbell & Co Investment Adviser first reported a position in Rentokil in Q2 2023 and has held it in 6 quarters since.
  • Campbell & Co Investment Adviser's Rentokil position peaked at $1.95M in Q3 2023.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.